TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.43%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.07%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
188
New
16
Increased
27
Reduced
40
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$42.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$29.7M |
| 3 |
Moderna
MRNA
|
$22.1M |
| 4 |
Danaher
DHR
|
$17.7M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$16.4M |
Top Sells
| 1 |
Biogen
BIIB
|
$23.6M |
| 2 |
Exact Sciences
EXAS
|
$21.5M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$19.2M |
| 4 |
Cigna
CI
|
$18M |
| 5 |
Dentsply Sirona
XRAY
|
$17.3M |
Sector Composition
| 1 | Healthcare | 96.33% |
| 2 | Real Estate | 2.82% |
| 3 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ascendis Pharma
ASND
$11.8B
| $9.12M | 0.29% |
67,794
| – | – |
|
77
Omega Healthcare
OHI
$12.6B
| $9.07M | 0.29% |
306,433
| – | – |
|
78
Arrowhead Research
ARWR
$3.05B
| $8.94M | 0.29% |
134,812
-69,402
| -34% | -$4.6M |
|
79
Addus HomeCare
ADUS
$2.12B
| $7.82M | 0.25% |
83,632
| – | – |
|
80
Universal Health Services
UHS
$11.6B
| $7.78M | 0.25% |
60,023
| – | – |
|
|
IMAB
81
I-MAB
IMAB
$340M
| $7.71M | 0.25% |
162,580
| – | – |
|
82
AMN Healthcare
AMN
$796M
| $7.49M | 0.24% |
+61,201
| New | +$7.49M |
|
83
Theravance Biopharma
TBPH
$699M
| $7.25M | 0.23% |
656,296
| – | – |
|
84
Arvinas
ARVN
$568M
| $7.06M | 0.23% |
85,997
| – | – |
|
85
Sabra Healthcare REIT
SBRA
$4.58B
| $6.91M | 0.22% |
510,660
| – | – |
|
86
Intellia Therapeutics
NTLA
$1.22B
| $6.88M | 0.22% |
58,180
| – | – |
|
87
Elevance Health
ELV
$71.8B
| $6.79M | 0.22% |
14,644
| – | – |
|
88
Revvity
RVTY
$10.5B
| $6.72M | 0.22% |
33,444
| – | – |
|
89
Travere Therapeutics
TVTX
$1.56B
| $6.61M | 0.21% |
212,869
| – | – |
|
90
Alkermes
ALKS
$4.78B
| $6.45M | 0.21% |
277,309
-96,515
| -26% | -$2.24M |
|
91
Agilent Technologies
A
$35.7B
| $6.33M | 0.2% |
39,625
| – | – |
|
92
Smith & Nephew
SNN
$16.3B
| $6.29M | 0.2% |
181,710
| – | – |
|
|
LTC
93
LTC Properties
LTC
$1.68B
| $6.22M | 0.2% |
182,293
| – | – |
|
94
Sanofi
SNY
$121B
| $6.19M | 0.2% |
123,454
-29,800
| -19% | -$1.49M |
|
95
Philips
PHG
$26.2B
| $6.07M | 0.2% |
164,790
| – | – |
|
96
Qiagen
QGEN
$10.1B
| $6M | 0.19% |
107,855
| – | – |
|
97
Healthpeak Properties
DOC
$12.5B
| $5.43M | 0.17% |
150,392
| – | – |
|
98
Ionis Pharmaceuticals
IONS
$6.79B
| $5.35M | 0.17% |
175,680
-146,841
| -46% | -$4.47M |
|
|
RCM
99
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.16M | 0.17% |
202,351
| – | – |
|
|
VRNA
100
Verona Pharma
VRNA
$9.16B
| $5.05M | 0.16% |
751,905
| – | – |
|